BlackRock’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,729,571
| Closed | -$10.1M | – | 5003 |
|
|
2017
Q4 | $10.1M | Buy |
2,729,571
+720,462
| +36% | +$2.67M | ﹤0.01% | 3113 |
|
|
2017
Q3 | $8.22M | Buy |
2,009,109
+73,002
| +4% | +$299K | ﹤0.01% | 3228 |
|
|
2017
Q2 | $7.19M | Buy |
1,936,107
+1,399,496
| +261% | +$5.2M | ﹤0.01% | 3295 |
|
|
2017
Q1 | $2.22M | Buy |
+536,611
| New | +$2.22M | ﹤0.01% | 3582 |
|
|
2016
Q2 | – | Sell |
-550
| Closed | -$4K | – | 3817 |
|
|
2016
Q1 | $4K | Buy |
550
+225
| +69% | +$1.64K | ﹤0.01% | 3343 |
|
|
2015
Q4 | $4K | Hold |
325
| – | – | ﹤0.01% | 3195 |
|
|
2015
Q3 | $5K | Hold |
325
| – | – | ﹤0.01% | 3024 |
|
|
2015
Q2 | $7K | Sell |
325
-143
| -31% | -$3.08K | ﹤0.01% | 2985 |
|
|
2015
Q1 | $5K | Hold |
468
| – | – | ﹤0.01% | 3014 |
|
|
2014
Q4 | $5K | Hold |
468
| – | – | ﹤0.01% | 3060 |
|
|
2014
Q3 | $5K | Buy |
468
+174
| +59% | +$1.86K | ﹤0.01% | 3053 |
|
|
2014
Q2 | $6K | Buy |
294
+279
| +1,860% | +$5.69K | ﹤0.01% | 3052 |
|
|
2014
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 3156 |
|